Nymox Pharma (NYMX) Reports Q1 EPS of $0.04

Go back to Nymox Pharma (NYMX) Reports Q1 EPS of $0.04

Form 6-K NYMOX PHARMACEUTICAL For: Mar 31

May 15, 2015 5:22 PM EDT


FORM 6-K

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Report of Foreign Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934

For the period ended March 31, 2015

Commission File Number: 001-12033

... More